More and more women are seeking treatment for substance use disorders (SUDs). Although literature from Western countries points to the efficacy of cognitive-behavioral interventions, developed specifically to address the unique profiles of women with substance use disorders (wSUDs), literature from low- and middle-income countries is scarce. In India, there is a lack of studies examining the treatment needs of wSUDs, with the aim of developing an intervention program. In the present study, 8 experts in the field of addiction (mean age of 50.63 years), 8 wSUDs (mean age of 32.38 years), and 8 significant others (mean age of 41.13 years) were interviewed to elicit the focus and structure of a culturally sensitive and gender-responsive treatment for wSUDs in India. Interview recordings were transcribed, translated, coded, and examined using thematic analysis. The results revealed the need to include cognitive-behavioral coping-skills training and relapse-prevention strategies, along with sessions to address emotion dysregulation, women’s health, and parenting skills. The inclusion of significant others in the treatment was deemed crucial in overcoming familial barriers to entry and retention. Information about the desired frequency of sessions, the structure of each session, the duration of treatment, therapist characteristics, and requirements for the physical setting of the sessions emerged. A treatment program considering various cultural aspects of wSUDs is discussed.

No abstract

The aim of this study was to examine the subjective experience of pastlife regression (PLR). 15 graduate students underwent PLR facilitated by a trained professional for this purpose. Using Interpretative Phenomenological Analysis (IPA), the data collected from the interviews with these individuals was analyzed. The participants were able to relate their experiences under trace with their present life scenarios and could find meaning in their experiences. Most participants reported positive effects of the experience and this may have implications for further research and therapy with non-clinical populations.

No abstract

No abstract